Mrs. Kira Varner, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5500 94th Ave N, Brooklyn Park, MN 55443 Phone: 952-826-8475 |
Jenneh Koenig, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6516 Zealand Ave N, Brooklyn Park, MN 55428 Phone: 612-201-7623 |
Vinetta Renee Gladney, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8348 Idaho Ave N, Brooklyn Park, MN 55445 Phone: 612-743-0458 |
News Archive
Spectrum Pharmaceuticals today announced that it has acquired 100% rights to RenaZorb (a family of compounds represented by SPI-014, also known as RZB-014), a lanthanum-based nanotechnology compound with potent and selective phosphate binding properties, for all human and non-human indications.
ProteoTech, Inc., a privately held biotechnology company, has entered into a drug development agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech's small molecule technology platform against misfolded proteins to specifically advance work on its alpha-synuclein therapeutic program for the treatment of Parkinson's disease and other synucleinopathies.
The Miami Herald's Daniel Chang, working in partnership with Kaiser Health News, reports: "As health insurance companies shift more financial responsibility onto consumers through higher deductibles, co-payments and co-insurance rates, hospital executives are feeling pressure to reveal their most closely-held secret: prices. Last week, Miami Children's Hospital became one of the first in South Florida to give consumers more information -; but not exactly the prices -; they need to estimate their out-of-pocket costs, an increasingly important factor when deciding where to seek medical care" (Chang, 1/19).
A new preprint on the medRxiv* server provides more evidence that COVID-19 likely causes a more serious phenotype to arise in pregnant women.
The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depends on its ability to infect new host cells following its replication and release from infected cells. This pivots on its ability to bind to cell surface receptors like the ACE2 enzyme.
› Verified 4 days ago